Elicera Therapeutics appoints Johan Liwing

GOTHENBURG: Elicera Therapeutics AB (publ), a clinical-stage cell and gene therapy company developing next-generation cancer treatments based on oncolytic viruses and CAR T-cell therapies armed with immune-activating properties via its commercially available iTANK platform, announced Tuesday that it has appointed Johan Liwing as…